4 Contradicted by research
A measurement of 1.3 mm or higher on a carotid intima-media thickness (CIMT) test is classified as discrete plaque.
"In the bottom half, it starts with a thing which says something like uh plaque analysis and it says if you have 1.3 or higher then that then that's classified as what I would call discrete plaque." (said at 0:14:04)
Standard international consensus guidelines do not define discrete carotid plaque as a thickness of 1.3 mm or higher. According to the widely adopted Mannheim Carotid Intima-Media Thickness and Plaque Consensus, carotid plaque is defined as a focal wall encroachment into the arterial lumen of at least 0.5 mm, 50% or more of the surrounding IMT value, or an absolute total thickness of greater than 1.5 mm. While some proprietary commercial test reports or software may utilize non-standard arbitrary thresholds, established clinical consensus defines the absolute thickness threshold for plaque at >1.5 mm rather than 1.3 mm.
Grinding whole wheat berries at home renders the flour ultra-processed.
"there's some potential that getting your own wheat berries helps, but usually when you grind it up, you're again, your grinding it up is making it ultra-processed." (said at 0:50:48)
Under the internationally recognized NOVA food classification system, physical and mechanical operations applied to whole foods—such as grinding, milling, crushing, or drying whole grains—produce minimally processed foods (Group 1). Ultra-processed foods (Group 4) are defined by industrial formulations containing additives (such as emulsifiers, preservatives, or artificial flavorings) and industrial ingredients derived from foods through processing techniques not typically performed at home. Grinding whole wheat berries at home results in simple whole-wheat flour without additives or chemical extraction, meaning mechanical grinding does not make the food ultra-processed.
Half of all heart attacks result in sudden death.
"With heart attack, half of them result in sudden death. You wake up dead." (said at 0:55:36)
The speaker conflates several cardiovascular epidemiology statistics. It is not true that 50% of all heart attacks result in sudden death. Rather, published epidemiological data (such as from the Nurses' Health Study and Framingham Heart Study cohorts) demonstrate that sudden cardiac death (SCD) accounts for approximately half of all cardiac *deaths*, and that SCD frequently occurs as the initial clinical manifestation of undiagnosed coronary artery disease.
A coronary artery calcium score of 1,000 or above often indicates plaque stabilization and calcification associated with lower risk than lower scores with unstable plaque.
"having a calcium score 1,000 or above is often a marker that you've gotten your metabolic disease in line and that you have less risk than people with lower calcium scores... due to the stabilization, i.e., that plaque burden went up because the soft plaque is now hard plaque or calcified." (said at 1:17:48)
The claim that a coronary artery calcium (CAC) score of 1,000 or greater indicates lower cardiovascular risk than lower scores due to plaque stabilization is contradicted by clinical evidence. Large prospective cohort data, such as from the Multi-Ethnic Study of Atherosclerosis (MESA), demonstrate that individuals with CAC ≥ 1,000 are at very high cardiovascular risk (a 4.71-fold higher risk for all CVD events vs CAC 0 and a 1.65-fold higher risk vs CAC 400-999), with event rates comparable to patients with established secondary prevention disease. While increased calcium density at a given volume level is associated with plaque stabilization, an overall score of ≥ 1,000 reflects massive total coronary plaque burden and unequivocally denotes high risk rather than lower risk or controlled metabolic disease.
- context: Calcium density of coronary artery plaque and risk of incident cardiovascular events. (JAMA 2014) · cited 652x in the literature
"CAC volume was positively and independently associated with CHD and CVD risk. At any level of CAC volume, CAC density was inversely and significantly associated with CHD and CVD risk." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Even… (Circulation 2021) · cited 154x in the literature
"After full adjustment, CAC ≥1000 demonstrated a 4.71- (3.63-6.11), 7.57- (5.50-10.42), 4.86-(3.32-7.11), and 1.94-fold (1.57-2.41) increased risk for all CVD events, all coronary heart disease events, hard coronary heart disease events, and all-cause mortality, respectively, compared with CAC 0 and a 1.65- (1.25-2.16), 1.66- (1.22-2.25), 1.51- (1.03-2.23), and 1.34-fold (1.05-1.71) increased risk compared with CAC 400 to 999. With increasing CAC, hazard ratios increased for all event types, with no apparent upper CAC threshold." (abstract, results, passage verified)
pubmedfull study (doi)
4 Needs context
Approximately 80% of Americans eat cereal.
"Now, most of the people that are watching our videos uh really are not eating cereal, but when you think about it maybe or look it up, 80% of Americans are eating cereal." (said at 0:01:41)
The claim that approximately 80% of Americans eat cereal is roughly consistent with US consumer market research and household penetration surveys (which commonly report that 80% to 86% of Americans or US households purchase and consume cold breakfast cereal). However, based on nationally representative dietary survey data from the National Health and Nutrition Examination Survey (NHANES), on any given single day only about 19% of US adults report consuming ready-to-eat cereal. Thus, the 80% figure reflects general consumer/household penetration rather than daily consumption.
- context: Association between Ready-to-Eat Cereal Consumption and Nutrient Intake, Nutritional Adequ… (Nutrients 2019) · cited 21x in the literature
"Nineteen percent of US adults were ready-to-eat cereal eaters; they had a similar level of energy intake as non-eaters, but they had significantly higher intake of dietary fiber, and several vitamins and minerals, such as calcium, iron, magnesium, potassium, zinc, vitamin A, thiamin, riboflavin, niacin, vitamin B 6 , folate, vitamin B 12 , and vitamin D." (abstract, results, passage verified)
pubmedfull study (doi)
The Somogyi effect occurs when blood sugar drops very low in the early morning, triggering reactive fasting hyperglycemia.
"And there's also something very interesting a lot of people don't know, which is called the Somogyi effect, which is similar to the dawn effect, but this effect happens when your blood sugar goes extra low, very low in the early morning, and that's a trigger to high blood sugar, fasting blood sugar." (said at 0:27:47)
The speaker accurately defines the classical clinical concept of the Somogyi effect (or Somogyi phenomenon): rebound fasting hyperglycemia hypothesized to occur in response to nocturnal or early-morning hypoglycemia via counter-regulatory hormone release. However, modern clinical research using continuous glucose monitoring has largely challenged this hypothesis, demonstrating that nocturnal hypoglycemia rarely causes rebound morning hyperglycemia (morning glucose levels are typically lower after nocturnal hypoglycemic episodes, not higher) and that morning hyperglycemia is more often driven by the dawn phenomenon or waning overnight insulin levels.
- supports: Fasting hyperglycemia: etiology, diagnosis, and treatment. (Diabetes technology & therapeutics 2004) · cited 39x in the literature
"Fasting hyperglycemia generally can be attributed to inadequate or inappropriate hepatic insulinization or the dawn phenomenon (fasting hyperglycemia occurring in the absence of antecedent hypoglycemia). Less commonly, the Somogyi effect (marked fasting hyperglycemia following antecedent hypoglycemia) can cause fasting hyperglycemia." (abstract, background, passage verified)
pubmedfull study (doi) - context: Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fi… (Diabetic medicine : a journal of the British Diabetic Association 2013) · cited 27x in the literature
"The Somogyi effect postulates that nocturnal hypoglycaemia causes fasting hyperglycaemia attributable to counter-regulatory hormone release. Although most published evidence has failed to support this hypothesis, this concept remains firmly embedded in clinical practice... Fasting capillary blood glucose was lower after nights with hypoglycaemia than without [5.5 (3.0) vs. 14.5 (4.5) mmol/l, P < 0.0001]... Our data indicate that, in clinical practice, the Somogyi effect is rare." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - context: The Somogyi hypothesis: a parallelism with Michael Somogyi's life. (Hormones (Athens, Greece) 2025) · cited 3x in the literature
"He gave the name to the eponymous Somogyi effect or Somogyi hypothesis (in short, rebound hyperglycemia after insulin-induced hypoglycemia, particularly nocturnal), which was an axiom in the treatment of diabetes for decades. Although it is currently debated whether the Somogyi hypothesis is a real or relevant phenomenon in patients with diabetes..." (abstract, background, passage verified)
pubmedfull study (doi)
The most effective intervention to resolve sleep apnea is weight loss.
"the best thing you could do to fix a sleep apnea is to lose weight." (said at 1:02:59)
Weight loss is a highly effective, foundational lifestyle intervention for individuals with obstructive sleep apnea (OSA) who have overweight or obesity, significantly reducing the Apnea-Hypopnea Index (AHI) and associated cardiometabolic risks. However, calling it unconditionally the "best thing to fix" sleep apnea requires context: continuous positive airway pressure (CPAP) remains the clinical gold standard and first-line treatment for immediately eliminating airway obstruction, and weight loss alone often substantially reduces rather than completely resolves moderate-to-severe OSA. Furthermore, OSA in individuals without excess body weight may be driven primarily by craniofacial or other non-weight-related anatomical factors.
Carotid Intima-Media Thickness (CIMT) ultrasound can directly detect and visualize soft arterial plaque.
"One of the next places I will go is how about an old-fashioned CIMT? That's going to show me soft plaque." (said at 1:15:55)
Carotid duplex and B-mode ultrasound can identify carotid atherosclerotic plaques and evaluate their acoustic characteristics—specifically identifying echolucent (hypoechoic) areas, which are often described colloquially as 'soft plaque' and correlate with lipid-rich necrotic cores or intraplaque hemorrhage. However, the claim conflates Carotid Intima-Media Thickness (CIMT) measurement with plaque imaging/characterization. By standard consensus definitions (such as the Mannheim consensus), CIMT specifically measures the thickness of the intima-media layer in plaque-free arterial wall segments to assess early vascular remodeling, whereas distinct focal protrusions are classified as plaques. Furthermore, while quantitative ultrasound can image echolucent plaques, its diagnostic accuracy for reliably characterizing specific vulnerable components (like lipid-rich necrotic cores versus intraplaque hemorrhage) remains variable compared to advanced modalities such as high-resolution MRI.
- context: Intima-media thickness of carotid arteries. (Frontiers of neurology and neuroscience 2015) · cited 19x in the literature
"The recently updated Mannheim consensus defined and described how to differentiate CIMT from plaques. These definitions allow for the better analysis and quantification of early atherosclerosis." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Role of carotid plaque analysis in therapeutic decision-making for carotid disease. (International angiology : a journal of the International Union of Angiology 2025) · cited 1x in the literature
"Recently, specific features of the atherosclerotic plaque have attracted increasing attention; for example, total plaque area, juxtaluminal black area, intraplaque hemorrhage, and mainly echolucent plaques are associated with high risk of late stroke, and these features now influence the therapeutic choices." (abstract, results, passage verified)
pubmedfull study (doi) - context: Diagnostic accuracy of gray-scale analysis on B-mode ultrasound for identifying intraplaqu… (Vascular medicine (London, England) 2026)
"Though magnetic resonance imaging (MRI) can detect both, duplex ultrasound is more accessible and may identify echolucent plaque areas that correlate with IPH or LRNC... Conclusion:Quantitative ultrasound does not reliably predict the presence of IPH or LRNC, as detected by MRI, in patients with atherosclerotic internal CS." (abstract, conclusions)
pubmedfull study (doi)
16 Supported by research
Repeated glucose and insulin spikes wear down and damage the endothelial glycocalyx lining of artery walls, initiating plaque formation.
"Do that a few times a day, every day for a few years, and it wears down that inner lining of your artery wall, the glycocalyx. That's part of the endothelium. Think of it as that smooth inner surface of the pipe that your blood flows through. Those repeated spikes irritate it. They inflame it. They even damage it. When that inflamed, damaged wall is exactly where plaque starts to build." (said at 0:05:30)
The endothelial glycocalyx is a carbohydrate-rich, gel-like protective layer of proteoglycans and glycoproteins lining the luminal surface of vascular endothelial cells. Clinical physiological studies demonstrate that acute hyperglycemia causes rapid degradation and shedding of the glycocalyx layer via oxidative stress mechanisms. In human trials, acute experimental hyperglycemia halved systemic endothelial glycocalyx volume and led to endothelial dysfunction and coagulation activation. Destruction of the glycocalyx increases vascular permeability, facilitates low-density lipoprotein (LDL) infiltration, and permits leukocyte adhesion to the underlying endothelium, representing early initiating steps in atherosclerotic plaque formation.
- supports: Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfu… (Diabetes 2006) · cited 632x in the literature
"Hyperglycemia reduced glycocalyx volume (to 0.8 +/- 0.2 l; P < 0.05), and NAC was able to prevent the reduction (1.4 +/- 0.2 l)... Taken together, these data indicate a potential role for glycocalyx perturbation in mediating vascular dysfunction during hyperglycemia." (abstract, results)
pubmedfull study (doi) - supports: Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic proc… (QJM : monthly journal of the Association of Physicians 2008) · cited 123x in the literature
"That luminal hyperglycaemia causes glycocalyx dysfunction has already been shown; we postulate this to be the first step in the atherothrombotic process in patients with diabetes mellitus and metabolic syndrome (insulin resistance)." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: [Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and… (Archivos de cardiologia de Mexico 2014) · cited 15x in the literature
"Shredding of glycocalyx appears as an essential initial step in the pathophysiology of atherosclerosis and microangiopathic complications of diabetes mellitus... Atherosclerosis risk factors, as hypercholesterolemia (LDL), hyperglycemia, inflammation, salt excess and altered shear stress can damage glycocalyx. This lead to endothelial dysfunction and allows LDL and leukocytes to filtrate to the subendothelial space initiating atheroma plaque formation." (abstract, results)
pubmedfull study (doi)
Cortisol or epinephrine release upon waking or exercising fasted causes the liver to release stored glucose into the bloodstream.
"When you wake up or when you have a cortisol effect, that cortisol or epinephrine, adrenaline that you get from walking or just from waking up and f after your fast. Both of those can cause you to release cortisol or epinephrine and those in turn can cause your liver to release blood sugar." (said at 0:24:35)
Physiological studies confirm that early morning waking and exercise during fasting stimulate counterregulatory hormones, including cortisol and epinephrine (adrenaline), which promote hepatic glucose output (via glycogenolysis and gluconeogenesis) into the bloodstream.
- supports: Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans. (The Journal of physiology 1999) · cited 65x in the literature
"adrenaline infusion augmented the rise in hepatic glucose production early in exercise. Glucose uptake increased during exercise in +ADR and -ADR, but was lower and metabolic clearance rate was reduced in +ADR." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of ty… (The Journal of clinical endocrinology and metabolism 2004) · cited 129x in the literature
"In conclusion, 1) increases in GP in healthy control subjects with exercise intensity can be entirely attributed to increases in net hepatic glycogenolysis." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Demonstration of a dawn phenomenon in normal human volunteers. (Diabetes 1984) · cited 128x in the literature
"Plasma cortisol, epinephrine, and norepinephrine increased significantly from nocturnal nadirs between 4:00 and 6:30 a.m... These results indicate that a dawn-like phenomenon, initiated by an increase in glucose production, occurs in nondiabetic individuals." (abstract, results)
pubmedfull study (doi)
The HbA1c test misses over half of insulin resistance or metabolic health problems.
"No, not an A1C. The A1C misses over half of this problem. I'm talking about where you get fasting glucose and fasting insulin, then you take the sugar, an hour later you get glucose and insulin, and then an hour after that you get glucose and insulin." (said at 0:25:28)
Large population-based studies confirm that standard HbA1c thresholds miss more than half of cases of dysglycemia detected by oral glucose tolerance tests (OGTT). In national cohort evaluations (such as NHANES data), standard HbA1c screening cutoffs had sensitivities of only ~25% to 35% for detecting diabetes and prediabetes compared with OGTT-based classifications, yielding false-negative rates exceeding 60% to 75%. Furthermore, HbA1c reflects average blood glucose rather than dynamic insulin secretion; individuals with early insulin resistance frequently maintain normal glycemic and HbA1c levels through compensatory hyperinsulinemia, which is only captured when dynamic glucose and insulin responses are measured.
- supports: Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on… (Metabolic syndrome and related disorders 2014) · cited 138x in the literature
"Current cutoffs of HbA1c for diabetes (6.5%) or prediabetes (5.7%) exhibited low sensitivity (0.249 and 0.354, respectively) and high specificity in identifying patients diagnosed using both FPG and 2-hr glucose, resulting in large false-negative rates (75.1% and 64.9%)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the O… (Journal of clinical medicine 2020) · cited 38x in the literature
"With an OGTT diagnosis of diabetes, concordance was only 34% for the A1c assessment and 44% for the FPG assay. Delimited to older adults, agreement between the OGTT and A1c was only 25%, and between the OGTT and FPG, concordance was only 33.5%." (abstract, results, passage verified)
pubmedfull study (doi)
Approximately 90 percent of metabolic disease cases have not been diagnosed by typical healthcare providers.
"And Tom, it sounds like you know already 90% of this has not been diagnosed by by your doc, by the typical doc out there and the typical health care provider." (said at 0:31:55)
Nationally representative epidemiological data from the National Health and Nutrition Examination Survey (NHANES) consistently show that approximately 85% to 92% of adults with prediabetes—a primary marker of early metabolic disease—are unaware of their condition and have not received a formal diagnosis from a healthcare provider. For example, an analysis of NHANES data found that 92.0% of U.S. adults with prediabetes were unaware of their condition (PMID: 27612580), and an earlier NHANES analysis noted that only 4.8% of individuals meeting prediabetes criteria reported having received a formal diagnosis from their physician (PMID: 20724649).
Surveys from institutions such as Johns Hopkins found that three-quarters of primary care doctors and cardiologists do not know how to diagnose metabolic disease or prediabetes.
"multiple surveys have been done from places like Hopkins, and what they found was three-quarters of the local doctor, your local doctor who the current administration is referring you back to, don't know how to diagnose this problem. Three-quarters of them—internists, family practitioners, cardiologists—don't know how to diagnose this problem." (said at 0:34:24)
Surveys led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine examined primary care providers' (PCPs') knowledge of prediabetes screening, diagnostic criteria, and management. In a survey of mid-Atlantic primary care providers (Tseng et al., 2017), only 17% of PCPs correctly identified the laboratory parameters for diagnosing prediabetes using both fasting glucose and HbA1c (meaning 83%, or over three-quarters, failed to identify the full diagnostic criteria). A subsequent national survey of US PCPs (Tseng et al., 2019) similarly demonstrated widespread knowledge gaps regarding prediabetes laboratory diagnostic criteria and screening guidelines.
Repeated, continuous spikes of glucose and insulin cause arterial plaque formation.
"it's the continuous glucose spikes and insulin spikes what's causing the problem—the over and over and overexposure to high glucose and high insulin causing arterial plaque." (said at 0:36:40)
Substantial observational and mechanistic evidence confirms that repeated acute glucose spikes (glycemic variability) and elevated insulin levels (hyperinsulinemia) contribute directly to endothelial dysfunction, vascular inflammation, and the initiation and progression of arterial plaques. Continuous glucose monitoring and intravascular imaging studies show that acute glucose excursions provoke oxidative stress and correlate significantly with arterial endothelial damage, plaque instability, and coronary plaque vulnerability.
- supports: Relationship between fluctuations in glucose levels measured by continuous glucose monitor… (Cardiovascular diabetology 2013) · cited 286x in the literature
"Fluctuations in blood glucose level cause endothelial dysfunction and play a critical role in onset and/or progression of atherosclerosis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit V… (Circulation journal : official journal of the Japanese Circulation Society 2016) · cited 63x in the literature
"High MAGE measured early after the onset of first-episode ACS correlated with thinner fibrous cap thickness and higher prevalence of TCFA at the non-culprit plaque in the non-culprit vessel." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction. (Antioxidants (Basel, Switzerland) 2021) · cited 183x in the literature
"Endothelial dysfunction plays a critical role in atherosclerosis progression, leading to cardiovascular complications. There are significant associations between diabetes mellitus, oxidative stress, and endothelial dysfunction. Oxidative stress is increased by chronic hyperglycemia and acute glucose fluctuations induced by postprandial hyperglycemia in patients with diabetes mellitus." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Relationship between insulin and carotid atherosclerosis in the general population. The Br… (Stroke 1997) · cited 44x in the literature
"We conclude that both "hypoinsulinemia" and hyperinsulinemia are independent risk indicators of carotid atherosclerosis." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Patients with diabetes typically experience a 5- to 7-year delay before receiving a formal diagnosis.
"To think about that for somebody who has diabetes you have to wait for five to seven years to get the diagnosis done, it's—I learned this word three weeks ago: preposterous." (said at 0:37:18)
Epidemiological models evaluating the prevalence and progression of diabetic retinopathy at the time of clinical diagnosis estimate that the asymptomatic onset of type 2 diabetes typically precedes formal clinical diagnosis by approximately 4 to 7 years (with refined models estimating an average delay of about 6 years).
Half of all heart attacks occur in people with normal cholesterol levels.
"Half of all heart attacks happen in people with perfectly normal cholesterol." (said at 0:55:28)
A large observational study of 136,905 hospitalizations for coronary artery disease (including acute myocardial infarction) across 541 US hospitals found that almost half of patients admitted with CAD had low-density lipoprotein (LDL) cholesterol levels under 100 mg/dL, which was considered the standard optimal/normal threshold (Sachdeva et al., 2009). The mean LDL cholesterol level at admission was 104.9 mg/dL. While the majority of these patients had abnormal total lipid profiles when considering low high-density lipoprotein (HDL) cholesterol or high triglycerides, the assertion that roughly half of acute coronary events occur in individuals with normal or optimal LDL cholesterol levels is well-supported by observational registry data.
Beetroot and beetroot powder increase nitric oxide levels in the body.
"beetroot, a lot of people say, you know what, beets are great. They can help you actually increase your NO, nitric oxide." (said at 0:59:40)
Beetroot and beetroot products are rich in inorganic dietary nitrate (NO3-). Following ingestion, dietary nitrate is reduced to nitrite (NO2-) by commensal oral bacteria, which is then absorbed and further reduced to nitric oxide (NO) in the bloodstream and tissues through the enterosalivary nitrate-nitrite-NO pathway. Extensive randomized controlled trials and systematic reviews demonstrate that beetroot supplementation significantly elevates plasma nitrate and nitrite concentrations (the primary circulating biomarkers of nitric oxide production) and enhances nitric oxide bioavailability, leading to measurable physiological effects such as reduced blood pressure and improved vascular function.
Creatine supplementation converts to creatinine and can falsely suggest kidney failure on standard blood tests, whereas cystatin C testing avoids this artifact.
"creatine gets turned into creatinine and creatinine is how doctors measure the health of your kidneys. So sometimes people will take creatine, they increase their creatinine and their doctor thinks they're having kidney failure and that's not what's going on... And one of those is a cystatin C" (said at 1:00:25)
The speaker's claim is supported by randomized controlled clinical trial data. Creatine spontaneously degrades non-enzymatically into creatinine, which can raise serum creatinine levels and lead to a false clinical impression or misdiagnosis of renal impairment on standard creatinine-based tests. Using cystatin C (a marker independent of creatine intake and muscle mass) demonstrates normal glomerular filtration rate and confirms that renal function remains unaltered.
- supports: Effects of creatine supplementation on renal function: a randomized, double-blind, placebo… (European journal of applied physiology 2008) · cited 86x in the literature
"The decrease in cystatin C indicates that high-dose creatine supplementation over 3 months does not provoke any renal dysfunction in healthy males undergoing aerobic training." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Long-term creatine supplementation is safe in aged patients with Parkinson disease. (Nutrition research (New York, N.Y.) 2008) · cited 81x in the literature
"Although serum creatinine levels increased in Cr patients because of the degradation of Cr, all other markers of tubular or glomerular renal function, especially cystatin C, remained normal, indicating unaltered kidney function." (abstract, results, passage verified)
pubmedfull study (doi)
The USDA Dietary Guidelines recommend keeping saturated fat consumption to less than 10 percent of total daily calories.
"they're still recommending we eat four to five servings of fruits and vegetables and four servings of grains a day and keep our saturated fat to less than 10%?" (said at 0:30:14)
The claim is accurate. The USDA/HHS Dietary Guidelines for Americans consistently recommend limiting saturated fat intake to less than 10 percent of total daily calories.
Sleep apnea can occur in individuals with a normal BMI, including a BMI of 21.
"And you don't have to be fully overweight or obese to be dealing with sleep apnea... I had sleep apnea when my BMI was 21." (said at 1:03:28)
Obstructive sleep apnea (OSA) is not restricted to overweight or obese individuals and commonly occurs in people with a normal body mass index (BMI). An individual participant data meta-analysis of 12,860 adults across four community-based cohorts found that approximately 23.5% of adults diagnosed with OSA were normal weight or underweight (BMI < 25 kg/m²). In non-obese individuals, OSA is frequently driven by non-adipose factors, such as craniofacial skeletal morphology and airway anatomy.
Colchicine is an anti-inflammatory drug identified through Harvard research by Paul Ridker to reduce cardiovascular risk.
"colchicine is clearly an option. It's an it's an anti-inflammatory. And uh some very smart people uh Paul Ridker, Gavin Blake up at Harvard noticed that that statins actually are anti-inflammatories. So they went down this whole research train for the for the next 30 years looking at anti-inflammatories to see if they can decrease risk. Sure enough, that's how colchicine came up." (said at 1:10:42)
Substantial clinical trial and review evidence demonstrates that low-dose colchicine is an anti-inflammatory therapy that significantly reduces major adverse cardiovascular events (MACE) in patients with coronary artery disease and after myocardial infarction, leading to FDA approval for cardiovascular risk reduction. This development directly followed decades of research—spearheaded by Paul Ridker, Gavin Blake, and colleagues at Harvard and Brigham and Women's Hospital—establishing the inflammatory hypothesis of atherosclerosis and showing that statins and dedicated anti-inflammatory drugs confer cardiovascular protection by reducing vascular inflammation.
- supports: Are statins anti-inflammatory? (Current controlled trials in cardiovascular medicine 2000) · cited 104x in the literature
"Emerging evidence from both clinical trials and basic science studies suggest that statins have anti-inflammatory properties, which may additionally lead to clinical efficacy. Measurement of markers of inflammation such as high sensitivity C-reactive protein in addition to lipid parameters may help identify those patients who will benefit most from statin therapy." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic… (Journal of the American College of Cardiology 2023) · cited 186x in the literature
"For coronary artery disease patients already taking guideline-directed medical care, including statins, low-dose colchicine (0.5 mg/d orally) has been shown to safely lower major adverse cardiovascular events by 31% among those with stable atherosclerosis and by 23% after recent myocardial infarction... In June 2023, the U.S. Food and Drug Administration approved the use of low-dose colchicine to reduce the risk of myocardial infarction, stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease." (abstract, results, passage verified)
pubmedfull study (doi)
Gentle, slow walking in Zone 2 or below decreases blood sugar and blunts glucose spikes.
"just taking a gentle, slow walk. So, getting back to zone two or even less, you know, a gentle walk will often help you decrease that blood sugar and keep it down" (said at 1:17:35)
Randomized controlled trials and meta-analyses consistently demonstrate that gentle, light-intensity walking (or light activity performed at low aerobic intensities, such as Zone 2 or lower), especially when performed after a meal or to interrupt prolonged sitting, significantly lowers postprandial blood glucose levels and blunts glucose excursions compared to remaining seated or inactive.
- supports: The Acute Effects of Interrupting Prolonged Sitting Time in Adults with Standing and Light… (Sports medicine (Auckland, N.Z.) 2022) · cited 126x in the literature
"Light-intensity walking was shown to significantly attenuate postprandial glucose (∆ = - 0.72, 95% CI - 1.03, - 0.41; z = - 4.57, p < 0.001) and insulin (∆ = - 0.83, 95% CI - 1.18, - 0.48; z = - 4.66, p < 0.001) compared to continued sitting." (abstract, results, passage verified)
pubmedfull study (doi) - supports: After Dinner Rest a While, After Supper Walk a Mile? A Systematic Review with Meta-analysi… (Sports medicine (Auckland, N.Z.) 2023) · cited 51x in the literature
"Exercise, i.e., walking, has a greater acute beneficial impact on postprandial hyperglycemia when undertaken as soon as possible after a meal rather than after a longer interval or before eating." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Performing additional coronary procedures has been proven not to prevent heart attacks in stable patients.
"Then my question is, okay, we know that doing more procedures has been demonstrated it doesn't prevent a heart attack. What are you trying to cure at this point?" (said at 1:14:45)
Large-scale randomized controlled trials have demonstrated that in patients with stable ischemic heart disease, routine coronary revascularization (such as percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) added to guideline-directed optimal medical therapy does not reduce the incidence of myocardial infarction or all-cause mortality compared to optimal medical therapy alone. The primary benefit of revascularization in this population is symptom and angina relief rather than the prevention of future heart attacks or death.
- supports: Optimal medical therapy with or without PCI for stable coronary disease. (The New England journal of medicine 2007) · cited 4721x in the literature
"As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Initial Invasive or Conservative Strategy for Stable Coronary Disease. (The New England journal of medicine 2020) · cited 2439x in the literature
"Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Cardiac imaging scans can simultaneously assess both myocardial perfusion and plaque characterization to identify plaque type.
"I don't think both assessments are opposite, like you can have both the perfusion, but you can also have the plaque characterization where you know what type of plaque you have." (said at 1:33:20)
Contemporary non-invasive cardiac imaging, particularly comprehensive cardiac computed tomography (CCTA combined with CT myocardial perfusion imaging or CT-derived fractional flow reserve), enables the simultaneous evaluation of both functional myocardial perfusion/ischemia and anatomical vessel wall features. This includes plaque characterization such as identifying calcified, non-calcified, mixed, or high-risk low-attenuation plaque components in a single clinical session.
- supports: Non-Contrast and Contrast-Enhanced Cardiac Computed Tomography Imaging in the Diagnostic a… (Diagnostics (Basel, Switzerland) 2023) · cited 17x in the literature
"In addition, coronary CT angiography (CCTA) has become a gate-keeper to invasive coronary angiography (ICA) and revascularization in patients with acute chest pain by allowing the assessment not only of the extent of lumen stenosis, but also of its hemodynamic significance if combined with the measurement of fractional flow reserve or perfusion imaging. Moreover, CCTA provides a unique incremental value over functional testing and ICA by imaging the vessel wall, thus allowing the assessment of plaque burden, composition, and instability features" (abstract, passage verified)
pubmedfull study (doi) - supports: Current Status of Cardiac CT for Nuclear Medicine Professionals: Coronary Artery Disease E… (Nuclear medicine and molecular imaging 2024) · cited 2x in the literature
"Currently, cardiac CT serves as a potential "one-stop-shop" imaging modality for the comprehensive assessment of patients with suspected or known CAD by providing analysis of coronary anatomy, functional significance, and characterization of left ventricular myocardium in a single session." (abstract, passage verified)
pubmedfull study (doi)
5 No source found (not proven false)
NHANES survey data shows that over half of 18-year-olds in the US have some degree of insulin resistance.
"The NHANES, National Health and Nutrition Examination Survey, which was part of that survey, the census survey, looked and did testing and it found, hey, it's not 60-year-olds that have this problem. Yes, as you get older it's more common, but even at age 18, 18 years old, over half of us already have some degree of insulin resistance, and it gets worse every year." (said at 0:06:20)
No published record matching the claim that NHANES survey data shows over half of 18-year-olds in the United States have insulin resistance was located; this does not prove the claim false.
By age 60, the majority of adults have some degree of insulin resistance.
"And most people can't handle these foods because by our 60s, most of us already have some degree of insulin resistance." (said at 0:06:58)
No published record matching the claim that the majority of adults have some degree of insulin resistance by age 60 was located; this does not prove the claim false.
The 2025 USDA dietary guidelines state that individuals with certain chronic diseases may experience improved health outcomes when following a low carbohydrate diet.
"Here's what the guidelines 2025—I guess they came out this year. It says, "Individuals with certain chronic diseases may experience improved health outcomes when following a low carbohydrate diet. Work with your health care professional to identify and adopt a diet that is appropriate for you and your health condition."" (said at 0:30:14)
No published record matching the claim that the 2025 USDA dietary guidelines state that individuals with certain chronic diseases may experience improved health outcomes when following a low carbohydrate diet was located; this does not prove the claim false.
Infection-induced cortisol elevation typically raises blood sugar to 120-130 mg/dL for three to fifteen days.
"And I think the big issue is cortisol. Why are you having cortisol? Because you had an infection. To your point, how long does that uh should you see these 120s and 130s? And it's it's impossible to predict. It's usually not going to be a month, but it's usually anywhere from three to 15 days." (said at 1:15:36)
No published record matching the claim that infection-induced cortisol elevation typically raises blood glucose to 120-130 mg/dL for three to fifteen days was located; this does not prove the claim false. While acute infection triggers neuroendocrine stress responses—including cortisol and catecholamine release leading to stress-induced hyperglycemia—the magnitude and duration of glycemic elevation vary widely according to the severity of illness and individual metabolic factors, rather than following a defined 3- to 15-day timeframe or specific 120-130 mg/dL concentration range.
High-intensity interval training (HIIT) can raise blood glucose to 120-140 mg/dL in fat-adapted individuals through cortisol and epinephrine secretion.
"quite often when you're fat-adapted, even just some HIIT training will crank that blood sugar up to 120, 130, 140... whether it's from dawn-effect-related cortisol or from HIIT-training-related cortisol and epinephrine" (said at 1:17:05)
No published record matching the claim that high-intensity interval training (HIIT) raises blood glucose to 120-140 mg/dL in fat-adapted individuals through cortisol and epinephrine secretion was located; this does not prove the claim false.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.